Interleukin-1 receptor antagonist isoforms in collagen-induced arthritis.

被引：0
|
作者：
Gabay, C
Williams, RO
Butler, DM
Porter, B
Feldmann, M
Arend, WP
机构：
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Denver, CO 80262 USA
[2] Kennedy Inst Rheumatol, London W6 8LH, England
来源：
ARTHRITIS AND RHEUMATISM | 1998年 / 41卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1084
引用
收藏
页码：S213 / S213
页数：1
相关论文
共 50 条
  • [11] Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist
    J-M Kim
    J-G Jeong
    S-H Ho
    W Hahn
    E-J Park
    S Kim
    S S Yu
    Y-W Lee
    S Kim
    Gene Therapy, 2003, 10 : 1543 - 1550
  • [12] Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist
    Kim, JM
    Jeong, JG
    Ho, SH
    Hahn, W
    Park, EJ
    Kim, S
    Yu, SS
    Lee, YW
    Kim, S
    GENE THERAPY, 2003, 10 (18) : 1543 - 1550
  • [13] THE EFFECT OF AN INTERLEUKIN-1 RECEPTOR ANTAGONIST PROTEIN ON TYPE-II COLLAGEN-INDUCED ARTHRITIS AND ANTIGEN-INDUCED ARTHRITIS IN MICE
    WOOLEY, PH
    WHALEN, JD
    CHAPMAN, DL
    BERGER, AE
    RICHARD, KA
    ASPAR, DG
    STAITE, ND
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : 1305 - 1314
  • [14] Effect of montelukast, a cysteinyl leukotriene receptor antagonist, on the progression of collagen-induced arthritis.
    Shiota, Naotaka
    Shimoura, Keiko
    Okunishi, Hideki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 166P - 166P
  • [15] INTERLEUKIN-1 POTENTIATES THE DEVELOPMENT OF COLLAGEN-INDUCED ARTHRITIS IN MICE
    KILLAR, LM
    DUNN, CJ
    CLINICAL SCIENCE, 1989, 76 (05) : 535 - 538
  • [16] Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of. interleukin-1 in collagen-induced arthritis
    Smeets, RL
    van de Loo, FAJ
    Joosten, LAB
    Arntz, OJ
    Bennink, MB
    Loesberg, WA
    Dmitriev, IP
    Curiel, DT
    Martin, MU
    van den Berg, WB
    ARTHRITIS AND RHEUMATISM, 2003, 48 (10): : 2949 - 2958
  • [17] Development of interleukin-1 receptor antagonist mutants with enhanced antagonistic activity in vitro and improved therapeutic efficacy in collagen-induced arthritis
    Dahlen, Eva
    Barchan, Karin
    Herrlander, Daniel
    Hojman, Patrik
    Karlsson, Marie
    Ljung, Lill
    Andersson, Mats
    Backman, Eva
    Hager, Ann-Christin Malmborg
    Walse, Bjoern
    Joosten, Leo
    van den Berg, Wim
    JOURNAL OF IMMUNOTOXICOLOGY, 2008, 5 (02) : 189 - 199
  • [18] Mice deficient in interleukin-1 receptor antagonist (IL-1ra) develop more severe collagen-induced arthritis (CIA)
    Zhou, F
    He, XW
    McPike, J
    Iwakura, Y
    Stuart, JM
    FASEB JOURNAL, 2005, 19 (04): : A329 - A329
  • [19] Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis - A possible role in the resolution of arthritis
    Gabay, C
    Marinova-Mutafchieva, L
    Williams, RO
    Gigley, JP
    Butler, DM
    Feldmann, M
    Arend, WP
    ARTHRITIS AND RHEUMATISM, 2001, 44 (02): : 451 - 462
  • [20] Interleukin-1 receptor antagonist gene polymorphism: A susceptibility factor to rheumatoid arthritis.
    Carreira, PE
    GonzalezCrespo, MR
    Pablos, JL
    Santiago, B
    Ciruelo, E
    delaCamara, AG
    GomezReino, JJ
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 763 - 763
12345